These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 38468469)
1. SP140 inhibitor suppressing TRIM22 expression regulates glioma progress through PI3K/AKT signaling pathway. Li X; Li G; Li L; Gao B; Niu X; Wang Y; Wang Z Brain Behav; 2024 Mar; 14(3):e3465. PubMed ID: 38468469 [TBL] [Abstract][Full Text] [Related]
2. TRIM22 actives PI3K/Akt/mTOR pathway to promote psoriasis through enhancing cell proliferation and inflammation and inhibiting autophagy. Ren Y; Dong H; Jin R; Jiang J; Zhang X Cutan Ocul Toxicol; 2022 Dec; 41(4):304-309. PubMed ID: 36170453 [TBL] [Abstract][Full Text] [Related]
3. TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway. Li L; Qi Y; Ma X; Xiong G; Wang L; Bao C Cell Biol Int; 2018 Sep; 42(9):1192-1199. PubMed ID: 29762880 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of autophagy induced by activation of the AMPK/ERK/mTOR signaling pathway after TRIM22-mediated DENV-2 infection of HUVECs. Wu N; Gou X; Hu P; Chen Y; Ji J; Wang Y; Zuo L Virol J; 2022 Dec; 19(1):228. PubMed ID: 36587218 [TBL] [Abstract][Full Text] [Related]
5. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter. Zhang J; Yang Y; Dong Y; Liu C Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078 [TBL] [Abstract][Full Text] [Related]
6. Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma. Zheng ZQ; Zhang GG; Yuan GQ; Hao JH; Nie QQ; Zheng MC; Wang Z Front Genet; 2023; 14():1148126. PubMed ID: 37284062 [No Abstract] [Full Text] [Related]
7. Induction of TRIM22 by IFN-γ Involves JAK and PC-PLC/PKC, but Not MAPKs and pI3K/Akt/mTOR Pathways. Gao B; Xu W; Wang Y; Zhong L; Xiong S J Interferon Cytokine Res; 2013 Oct; 33(10):578-87. PubMed ID: 23659673 [TBL] [Abstract][Full Text] [Related]
8. FOXC1‑mediated TRIM22 regulates the excessive proliferation and inflammation of fibroblast‑like synoviocytes in rheumatoid arthritis via NF‑κB signaling pathway. Wei Y; Huang X; Ma Y; Dai L Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35946462 [TBL] [Abstract][Full Text] [Related]
9. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway. Li Y; Ma X; Wang Y; Li G Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210 [TBL] [Abstract][Full Text] [Related]
10. Cinnamaldehyde Downregulation of Sept9 Inhibits Glioma Progression through Suppressing Hif-1 Wang Z; Wang C; Fu J; Liu R; Zhou X Dis Markers; 2022; 2022():6530934. PubMed ID: 35096204 [TBL] [Abstract][Full Text] [Related]
11. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway. Liao YX; Zhang ZP; Zhao J; Liu JP Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971 [TBL] [Abstract][Full Text] [Related]
12. Neuroglobin promotes the proliferation and suppresses the apoptosis of glioma cells by activating the PI3K/AKT pathway. Zhang B; Liu Y; Li Y; Zhe X; Zhang S; Zhang L Mol Med Rep; 2018 Feb; 17(2):2757-2763. PubMed ID: 29207186 [TBL] [Abstract][Full Text] [Related]
13. TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis. Zhang L; Zhang B; Wei M; Xu Z; Kong W; Deng K; Xu X; Zhang L; Ζhao X; Yan L Int J Oncol; 2020 May; 56(5):1225-1239. PubMed ID: 32319602 [TBL] [Abstract][Full Text] [Related]
14. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα. Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880 [TBL] [Abstract][Full Text] [Related]
15. RPA3 promotes the proliferation, migration, and invasion of gliomas by activating the PI3K-AKT-mTOR pathway. Liang L; Zhao Z; Jin Q; Zhang S; Zhao Z; Li X Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):80-86. PubMed ID: 37571896 [TBL] [Abstract][Full Text] [Related]
16. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling. Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015 [TBL] [Abstract][Full Text] [Related]
17. miR-93 promotes cell proliferation in gliomas through activation of PI3K/Akt signaling pathway. Jiang L; Wang C; Lei F; Zhang L; Zhang X; Liu A; Wu G; Zhu J; Song L Oncotarget; 2015 Apr; 6(10):8286-99. PubMed ID: 25823655 [TBL] [Abstract][Full Text] [Related]
18. STEAP3 is a prognostic biomarker that promotes glioma progression by regulating immune microenvironment and PI3K-AKT pathway. Song Z; Zhao Z; Zhu S; Jin Q; Shi Y; Zhang S; Wang Z; Wang Y; Zhao Z Cancer Biomark; 2023; 38(4):505-522. PubMed ID: 37980651 [TBL] [Abstract][Full Text] [Related]
19. Ubiquitin Ligase TRIM22 Inhibits Ovarian Cancer Malignancy via TCF4 Degradation. Tao T; Zhang Y; Guan C; Wang S; Liu X; Wang M Mol Cancer Res; 2024 Oct; 22(10):943-956. PubMed ID: 38842601 [TBL] [Abstract][Full Text] [Related]
20. TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1. Fei X; Dou YN; Sun K; Wei J; Guo Q; Wang L; Wu X; Lv W; Jiang X; Fei Z Exp Mol Med; 2023 Jun; 55(6):1203-1217. PubMed ID: 37258577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]